drugset / Trial / NCT02855658

Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome

NCT02855658 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

To evaluate the modulation of immunity-related gene expression for the Sjögren's syndrome under Chinese herbal medicine (SS-1) treatment.

Timeline

Start
2014-02
Primary completion
2016-10
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject SS-1 Cell therapy 6 g Oral

Indications